Statement on safety of cannabidiol as a novel food: data gaps and uncertainties.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA); Turck D, Bohn T, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Poulsen M, Prieto Maradona M, Schlatter JR, Trezza V, van Loveren H, Albert O, Dumas C, Germini A, Gelbmann W, Kass G, Kouloura E, Noriega Fernandez E, Rossi A, Knutsen HK.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
EFSA J. 2022 Jun 7;20(6):e07322. doi: 10.2903/j.efsa.2022.7322. eCollection 2022 Jun.
EFSA J. 2022.
PMID: 35686177
Free PMC article.
Consequently, EFSA has issued this statement, summarising the state of knowledge on the safety of CBD consumption and highlighting areas where more data are needed. ...Considering the significant uncertainties and data gaps, the Panel concludes that the safety of CB …
Consequently, EFSA has issued this statement, summarising the state of knowledge on the safety of CBD consumption and highlighting ar …